Experience
Ferring B.V.
Watson Laboratories, Inc.; Apotex Inc.
Represented Ferring in Hatch-Waxman patent infringement litigations, and related appeals, against Watson and Apotex concerning Ferring’s Lysteda®.
Ferring B.V. v. Watson Laboratories, Inc.; Apotex Inc., 3:11-cv-00481, D. Nev., Judges Cooke, Jones, McKibben
Ferring B.V. v. Watson Laboratories, Inc., 2:15-cv-04222, D.N.J., Judges Chesler, Hayden, Waldor
Valeant Pharmaceuticals Int’l, Inc. v. Mylan Pharmaceuticals, Inc.
Valeant; Salix; Progenics
Cephalon, Inc. v. Sun Pharmaceuticals Industries, Inc.
Cephalon, Inc.
Finnegan secures 10 years of patent protection for Relistor®
Valeant; Salix; Progenics
Dow Pharmaceutical Sciences, Inc. v. Tolmar, Inc.
Dow Pharmaceutical Sciences, Inc.
Horizon Pharma v. Dr. Reddy's Laboratories, et al.
Horizon Pharma
Akzo Pharma International BV v. Steris Laboratories Incorporated
Akzo Pharma International BV
Medicis Pharmaceutical Corp. v. Apotex, Inc.
Medicis Pharmaceutical Corp.
L'Oreal S.A. v. Clairol Inc. and Estee Lauder, Inc.
L'Oreal, S.A.
Ferring B.V. v. Allergan, Inc.
Ferring B.V.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.